10.85

0.37% -0.04

After Hours: 10.85

Exozymes Inc (EXOZ)

Overview News Price History Discussions Forecast

Exozymes Inc stock is traded at $10.85, with a volume of 8,639. It is down -0.37% in the last 24 hours and up +9.05% over the past month. EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.

Previous Close:

$10.89

Open:

$11.345

24h Volume:

8,639

Relative Volume:

1.07

Market Cap:

$103.39M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-3.21%

1M Performance:

+9.05%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$10.50

$11.65

1-Week Range:

$10.50

$11.96

52-Week Range:

$9.75

$22.63

Exozymes Inc Stock (EXOZ) Company Profile

Name

Exozymes Inc

Sector

Healthcare (1150)

Industry

Biotechnology (676)

Phone

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

EXOZ's Discussions on Twitter

Compare EXOZ with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EXOZ Exozymes Inc	10.85	103.39M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	500.19	127.64B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	603.58	65.95B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	656.65	37.92B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	273.55	32.98B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	254.16	26.92B	3.81B	-644.79M	-669.77M	-6.24

Exozymes Inc Stock (EXOZ) Latest News

Apr 22, 2025

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant - ADVFN

Apr 22, 2025

eXoZymes creates AI-engineered enzymes for biomanufacturing - Scientific Computing World

Apr 22, 2025

Apr 21, 2025

eXoZymes Inc. Introduces 'Exozymes' Terminology in Cover Story of GEN Biotechnology to Advance Cell-Free Biomanufacturing - Nasdaq

Apr 21, 2025

Bringing clarity and precision to the cell-free space by introducing exozymes | Daily Guardian - dailyguardian.ca

Apr 21, 2025

Bringing clarity and precision to the cell-free space by introducing exozymes - GlobeNewswire

Apr 21, 2025

Apr 14, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 14, 2025

Apr 11, 2025

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BIOVie’s Dr. Joe Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice - Yahoo Finance

Apr 11, 2025

New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CEO Julia Qian, BioVie's Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vic - ACCESS Newswire

Apr 11, 2025

EXoZymes Inc. Announces Its Latest Initiative BioClick - MarketScreener

Apr 11, 2025

Apr 10, 2025

Game-Changing BioClick Platform Secures NIH Grant for Next-Gen Drug Development - Stock Titan

Apr 10, 2025

Apr 06, 2025

eXoZymes appoints Damien Perriman as Chief Commercial Officer - World Bio Market Insights

Apr 06, 2025

Apr 02, 2025

eXoZymes Inc. Reports 2024 Progress and IPO Success - TipRanks

Apr 02, 2025

eXoZymes Provides Fourth Quarter and Full Year 2024 Update - GlobeNewswire

Apr 02, 2025

eXoZymes appoints new chief commercial officer By Investing.com - Investing.com Canada

Apr 02, 2025

eXoZymes appoints new chief commercial officer - Investing.com

Apr 02, 2025

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO - GlobeNewswire

Apr 02, 2025

Strategic Win: eXoZymes Taps 20-Year Biotech Leader to Drive Commercial Growth - Stock Titan

Apr 02, 2025

Mar 31, 2025

MDB Capital's Remarkable Growth: AUM Soars 2100%, New Platform Launch Drives Expansion - Stock Titan

Mar 31, 2025